Studies by Seminog and Goldacre (105) determined that patients with pathogenic mutations in the NF1 gene have a higher risk of colon cancer compared to the general population, supporting our findings in the patient analyzed (105). This evidence concerns the gene NF1 and colonic neoplasm.